Display Settings:

Format

Send to:

Choose Destination
    Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5. Epub 2005 Sep 2.

    An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

    Source

    Genome Institute of Singapore, 60 Biopolis Street, Singapore 138672. millerl@gis.a-star.edu.sg

    Erratum in

    • Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17882.

    Abstract

    Perturbations of the p53 pathway are associated with more aggressive and therapeutically refractory tumors. However, molecular assessment of p53 status, by using sequence analysis and immunohistochemistry, are incomplete assessors of p53 functional effects. We posited that the transcriptional fingerprint is a more definitive downstream indicator of p53 function. Herein, we analyzed transcript profiles of 251 p53-sequenced primary breast tumors and identified a clinically embedded 32-gene expression signature that distinguishes p53-mutant and wild-type tumors of different histologies and outperforms sequence-based assessments of p53 in predicting prognosis and therapeutic response. Moreover, the p53 signature identified a subset of aggressive tumors absent of sequence mutations in p53 yet exhibiting expression characteristics consistent with p53 deficiency because of attenuated p53 transcript levels. Our results show the primary importance of p53 functional status in predicting clinical breast cancer behavior.

    PMID:
    16141321
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1197273
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Fig. 3.
    Fig. 2.
    Fig. 1.
    Fig. 4.

      Supplemental Content

      Click here to read Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk